Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment

Ann Rheum Dis. 2005 Jul;64(7):1098-9. doi: 10.1136/ard.2004.026252.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infliximab
  • Lymphoma, B-Cell / chemically induced*
  • Lymphoma, B-Cell / immunology
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use
  • Middle Aged
  • Neoplasm Regression, Spontaneous*
  • Paranasal Sinus Neoplasms / chemically induced*
  • Paranasal Sinus Neoplasms / immunology

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab
  • Methotrexate